L-Mimosine is a naturally occurring plant amino acid and iron chelator that arrests the cell cycle in the late G 1 phase, although its mechanism of action is not known. Some studies indicate that mimosine prevents the initiation of DNA replication, whereas other studies indicate that mimosine disrupts elongation of the replication fork by impairing deoxyribonucleotide synthesis by inhibiting the activity of the iron-dependent enzyme ribonucleotide reductase and the transcription of the cytoplasmic serine hydroxymethyltransferase gene (SHMT1). In this study, the mechanism for mimosineinduced inhibition of SHMT1 transcription was elucidated. A mimosine-responsive transcriptional element was localized within the first 50 base pairs of the human SHMT1 promoter by deletion analyses and gel mobility shift assays. The 50-base-pair sequence contains a consensus zinc-sensing metal regulatory element (MRE) at position ؊44 to ؊38, and mutation of the MRE attenuated mimosine-induced transcription repression. Mimosine treatment eliminated MRE-and Sp1-binding activity in nuclear extracts from MCF-7 cells but not in nuclear extracts from a mimosine-resistant cell line, MCF-7/2a. MCF-7 cells cultured in zinc-depleted medium for more than 16 days were viable and lacked cytoplasmic serine hydroxymethyltransferase protein, confirming that mimosine inhibits SHMT1 transcription by chelating zinc. The disruption of DNA-protein interactions by zinc chelation provides a general mechanism for the inhibitory effects of mimosine on nuclear processes, including replication and transcription. Furthermore, this study establishes that SHMT1 is a zinc-inducible gene, which provides the first mechanism for the regulation of folate-mediated one-carbon metabolism by zinc.
Mimosine is an amino acid found in plants of the Mimosa and Leucaena genera and a tyrosine analog (1) . It is a cell-specific inhibitor of DNA replication in vivo; sensitive cell lines include human MCF-7 (2), HL60 (3) and Chinese hamster ovary (4), whereas human neuroblastoma (2), K562 (3) , and Xenopus and mouse embryonic cells are resistant (5, 6) . Mimosine is an effective iron chelator and a structural analog of deferiprone, a compound that is used clinically to lower systemic iron in patients who suffer from iron overload (7, 8) (Fig. 1) .
Mimosine arrests cell cycle progression in late G 1 and although it elicits a plethora of biological effects, its mechanism of action has not been established. Mimosine has been proposed to arrest DNA synthesis at the replication fork by repressing deoxyribonucleotide synthesis (9 -12) . Mimosine and deferoxamine inhibit the activity of the iron-dependent enzyme ribonucleotide reductase in vitro by chelating iron (9, 11, 12) and deplete cellular deoxyribonucleotide pools in some but not all studies (2, 12) . Furthermore, mimosine and deferoxamine have been shown to inhibit the transcription of the cytoplasmic serine hydroxymethyltransferase gene (SHMT1) 1 in MCF-7 cells but not in mimosine-resistant SH-SY5Y neuroblastoma (2) . The cytoplasmic serine hydroxymethyltransferase enzyme (CSHMT) catalyzes the tetrahydrofolate-dependent conversion of serine to glycine, a reaction that generates folate-activated one-carbon units that are required for purine, thymidine, and methionine biosynthesis (13) . Therefore, it has been proposed that mimosine may impair deoxyribonucleotide biosynthesis by inhibiting CSHMT and ribonucleotide reductase (5, 14) . Other studies demonstrate that mimosine disrupts the initiation phase of DNA replication at the origins of replication in Chinese hamster ovary cells. Mimosine is novel in this regard; it prevents formation of replication intermediates (4, 10) . Mimosine also affects gene expression at the level of transcription and translation. Mimosine increases the expression of p21 WAF-1 (5, 15) and p27 kip1 (16) while decreasing the transcription of the SHMT1 (2), Mcp-1, and Mip-2 (17) genes and depleting cyclin D levels (11) . Mimosine also inhibits the activity of several enzymes in vitro including tyrosinase, dopamine ␤-hydroxylase, deoxyhypusyl hydroxylase, and H1 kinase (3). However, none of these effects provide a definitive mechanism for cell cycle arrest, nor do they account for the cell-specific effects that mimosine exerts. In this study, we elucidated the molecular mechanism for mimosine-induced transcriptional repression of the human SHMT1 gene to provide insight into its inhibitory effect on cell cycle progression.
EXPERIMENTAL PROCEDURES
Materials-Fetal bovine serum and ␣-minimal essential medium (␣MEM) were obtained from Hyclone Laboratories. Zinc-depleted fetal bovine serum was prepared as described elsewhere (18) . Mammary adenocarcinoma (MCF-7) cells and the mimosine-resistant cell line MCF-7/2a (2) were maintained in ␣MEM with 11% fetal calf serum at 37°C in a 5% CO 2 atmosphere. Mimosine was purchased from Sigma. Oligonucleotides were purchased from Sigma Genosys; pfu Taq polymerase and dNTPs were from Stratagene, and [␥-32 P]dATP was purchased from PerkinElmer Life Sciences. * This work was supported by National Institutes of Health Grant PHS DK58144 (to P. J. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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Generation of SHMT1 Promoter Deletion Fragments-The human SHMT1 proximal promoter Ϫ409 to Ϫ1, and all deletion and mutated fragments thereof were cloned 5Ј of the firefly luciferase gene in the basic (promoterless) pGL3 reporter plasmid (Promega). Fragments of the promoter were generated by PCR and sequence verified. The following primer pairs were used to generate promoter fragments: for the Ϫ298 to Ϫ109 fragment, the forward primer was 5Ј-ATGCGCTAGCG-TAGTACCATGAAC-3Ј, and the reverse primer was 5Ј-ATGCAGATCT-GTTTCTCCGGGGCGG-3Ј; for the Ϫ409 to Ϫ237 fragment, the forward primer was 5Ј-ATGCGCTAGCTAATAATAATAAAGTGTCTGC-3Ј, and the reverse primer was 5Ј-ATGCAGATCTCCTTCCTCACTTAAGC-CTG-3Ј; for the Ϫ219 to Ϫ50 fragment, the forward primer was 5Ј-ATGCGCTAGCGGAAATCTTGGTCCAC-3Ј, and the reverse primer was 5Ј-CATAGATCTGCCGCCACCAAACGCACCAAACGCACC-3Ј. The following serial promoter deletion fragments were generated using a common reverse primer 5Ј-ATGCAGATCTTTGGGCTTGGCCCCG-3Ј. The forward primer for the Ϫ219 to Ϫ1 fragment was 5Ј-AT-GCGCTAGCGGAAATCTTGGTCCAC-3Ј; the forward primer for the Ϫ100 to Ϫ1 fragment was 5Ј-AGCTGCTAGCGCTTGGCTGC-3Ј; the forward primer for the Ϫ75 to Ϫ1 fragment was 5Ј-AGCTGCTAGC-CGGGTGCGTTG-3Ј; the forward primer for the Ϫ50 to Ϫ1 fragment was 5Ј-AGCTGCTAGCCGCCGCTGCGC-3Ј. The underlined sequences on the forward and reverse primers indicate NheI and BglII restriction endonuclease sequences, respectively, that facilitated the cloning into the pGL3 vector. For all primer sets, the cycling conditions were 94°C for 30 s, 65°C for 40 s, and 72°C for 7 min for 30 cycles. The concatenated vector ((Ϫ219 to Ϫ1)(-50 to Ϫ1)) was constructed by cloning a double-stranded oligonucleotide identical to the sequence Ϫ50 to Ϫ1 at the 3Ј end of the Ϫ219 to Ϫ1 fragment in the basic pGL3 vector. Mutations were generated using the QuikChange site-directed mutagenesis kit (Stratagene), and the sequence was verified. To mutate the nuclear factor 1 (NF1) site, the forward oligonucleotide primer was 5Ј-GGTGGCGGCCCATGCGGTGCTGCGCTCTCTGATTGGGCG-3Ј, and the reverse primer was 5Ј-CGCCCAATCAGAGAGCGCAGCACC-GCATGGGCCGCCACC-3Ј. To mutate the metal response element (MRE) site, the forward oligonucleotide primer was 5Ј-GGTGGCGGC-CCATGCTTGGCTATTCTCTCTGATTGGGCG-3Ј, and the reverse primer was 5Ј-CGCCCAATCAGAGAGAATAGCCAAGCATGGGCCGC-CACC-3Ј. Bold letters indicate base pair changes in the NF1/MRE element. The cycling conditions were 95°C for 30 s, 55°C for 30 s, and 72°C for 1 min for 30 cycles.
Gene Reporter Assays-MCF-7 cells were seeded in 96-well plates and upon attachment were treated with equal volumes of phosphatebuffered saline or mimosine (final concentration of 100 M) for 24 h prior to transfection. Cells were transfected with one of various SHMT1 promoter constructs using FuGENE transfectamine (Roche Applied Science) following the manufacturer's protocol and cultured for an additional 24 h in culture medium that contained (experimental) or lacked 
FIG. 2.
Transcriptional repression of the SHMT1 proximal promoter by mimosine. MCF-7 cells were cultured in the presence and absence of 100 M mimosine for 24 h and then transiently transfected with plasmids containing either the control SV40 promoter or SHMT1 5Ј-proximal promoter sequences cloned 5Ј to the firefly luciferase cDNA in the promoterless vector pGL3-basic. Firefly luciferase activity serves as an indicator of promoter activity and was assayed 24 h following transfection. Firefly luciferase activity was normalized to Renilla luciferase activity, which results from the co-transfection of a control plasmid as described under "Experimental Procedures." Data are presented as relative luciferase activity (the ratio of firefly/Renilla luciferase activity). Black bars indicate normalized firefly luciferase activity in untreated cells; white bars indicate normalized firefly luciferase activity in mimosine-treated cells. All values are the average of three measurements, and variance is displayed as the standard error of the mean. Inhibition of promoter activity by mimosine is indicated by the percentages that appear at the top of the black bars. Site-specific mutagenesis was used to alter three base pairs in the NF1 element of the construct Ϫ219 to Ϫ1 from 5Ј-TTGGCT-3Ј to 5Ј-GGTGCT-3Ј. Site-specific mutagenesis was used to alter three base pairs in the MRE element of the construct Ϫ219 to Ϫ1 from 5Ј-TGCGCTC-3Ј to 5Ј-TATTCTC-3Ј.
(control) 100 M mimosine. Firefly luciferase activity was measured using Dual Glo luciferase kit (Promega) and normalized to Renilla luciferase activity that was generated from the co-transfected control pRL-cytomegalovirus vector. In all cases, luciferase activity measurements were corrected for background; all luciferase activity values were a minimum of 20-fold greater than background. All luciferase data is presented as a ratio of firefly luciferase to Renilla luciferase activity.
Nuclear Protein Preparation and Electromobility Shift Assays-MCF-7 cells were grown to 70 -80% confluence on 100-mm plates and then cultured in medium with or without 300 M mimosine for 48 h. Nuclei were isolated from fresh cell pellets as described elsewhere (19) . Double-stranded oligonucleotides representing the NF1/MRE element present in the SHMT1 promoter (Ϫ53 to Ϫ31) were 5Ј-end labeled using T4 polykinase and [␥-32 P]dATP. Reaction solutions containing 0.1 ng of labeled probe, 1.2 g of a poly(dI-dC) oligonucleotide, 300 g/ml bovine serum albumin, 5 g of nuclear protein, 20 mM HEPES, 20% glycerol, and 100 mM KCl at pH 7.9 were incubated at room temperature for 30 min and immediately loaded into a 6% non-denaturing polyacrylamide gel. Electrophoresis was performed at a constant 22 mA for 3h. Gels were dried, and bands were visualized by autoradiography. The sequence of oligonucleotides representing SHMT1 promoter fragments are shown below; bold letters indicate a change in base pairs from the NF1/MRE oligonucleotide: NF1/MRE, 5Ј-CTAGCCCCATGCTTGGCTGCGCTCTCTGATTA-3Ј; mutated NF1, 5Ј-CTAGCCCCATGCGAGACTGCGCTCTCTGATTA-3Ј; mutated MRE, 5Ј-CTAGCCCCATGCTTGGCTACAATCTCTGATTA-3Ј; Sp1, 5Ј-CTAGCGGTCCCTGCCCAGGTA-3Ј.
Western Analysis-MCF-7 and MCF-7/2a cells were passaged in either ␣MEM, zinc-deficient ␣MEM, zinc-deficient ␣MEM ϩ 4 M ZnCl, or ␣MEM ϩ 4 M ZnCl over a 40-day period. Cells were harvested every four days, and total CSHMT and glyceraldehyde-3-phosphate dehydrogenase protein levels were determined by Western blot analyses as described elsewhere (2) . The purified sheep anti-human CSHMT antibody (20) was used at a 1:50,000 dilution; rabbit anti-human glyceraldehyde-3-phosphate dehydrogenase antibody (Novus) was used at a 1:100,000 dilution.
RESULTS

Identification of Mimosine-responsive Transcriptional
Elements-A mimosine-responsive cis element was identified in the SHMT1 5Ј-promoter by comparing SHMT1 promoter activity in transiently transfected MCF-7 cells that were cultured in the presence and absence of 100 M mimosine (Fig. 2) . Mimosine inhibited the activity of the SV40 promoter by 27%, whereas the activity of the SHMT1 proximal promoter (Ϫ409 to Ϫ1) was inhibited by 96%. A mimosine-responsive element was localized to the first 50 base pairs of the SHMT1 promoter by serial deletion of the SHMT1 promoter in the 5Ј to 3Ј direction; a second mimosine-responsive element was indicated in the Ϫ219 to Ϫ50 promoter fragment. The mimosine-responsive promoter fragment Ϫ50 to Ϫ1 exhibited only 16% of the promoter activity associated with the Ϫ219 to Ϫ1 promoter fragment in the absence of mimosine treatment but displayed strong enhancer activity. The Ϫ50 to Ϫ1 promoter fragment is essential for the strong promoter activity associated with the Ϫ219 to Ϫ1 fragment as evidenced by the low promoter activity of the Ϫ219 to Ϫ50 fragment and the nearly 2-fold increase in the transcriptional activity of the Ϫ219 to Ϫ1 promoter fragment that resulted upon the insertion of a second copy of the Ϫ50 to Ϫ1 fragment 3Ј of the Ϫ219 to Ϫ1 promoter fragment. All enhancer activity associated with the Ϫ50 to Ϫ1 promoter fragment was lost upon mimosine exposure (Fig. 2) .
The mimosine responsive enhancer element Ϫ1 to Ϫ50 was analyzed for consensus transcriptional cis-acting sequences using the Transcription Element Sequence Survey. An overlapping NF1-(Ϫ49 to Ϫ44) (21) and MRE-(Ϫ44 to Ϫ38) (22) was identified as a candidate for the mimosine responsive cis-element (Fig. 3) . MRE enhancer elements often contain overlapping Sp1 binding sites, which are believed to confer negative regulation to the MRE (22) . MRE elements are present in the promoters of zinc-activated genes and are bound by the transcription factor MTF-1, an 80-kDa zinc finger DNA binding protein with transcriptional activation domains (22, 23) . Zinc is essential for MTF-1 binding to the MRE (23) . Mutation of the NF1 consensus sequence in the SHMT1 promoter Ϫ219 to Ϫ1 partially attenuated mimosine inhibition by ϳ20% without influencing SHMT1 promoter activity (Fig. 2) . Mutation of the consensus MRE sequence decreased the promoter activity of the Ϫ219 to Ϫ1 fragment by 60% in the absence of mimosine and attenuated mimosine inhibition by nearly 40%. From these studies, we conclude both that the MRE is a strong enhancer of SHMT1 transcription and that it contributes to the mimosine responsiveness of the SHMT1 gene.
Mimosine Inhibits MRE and Sp1 Binding Activity-The effect of mimosine on MRE and Sp1 binding activity was determined in nuclear extracts isolated from MCF-7 cells by gel mobility shift assays. Mimosine exposure did not affect qualitatively the SDS-PAGE profile of MCF-7 nuclear protein (Fig.  4) but did inhibit MRE and Sp1 binding activity. Nuclear extracts from MCF-7 cells bound a double-stranded oligonucleotide probe that contains the sequence of the overlapping NF1/MRE element Ϫ50 to Ϫ31 as is evident from the gel shift (Fig. 5) , whereas nuclear extracts from mimosine-treated cells displayed no or very weak binding activity. Mutation of the MRE consensus sequence weakened or eliminated binding activity in MCF-7 cell extracts, whereas MCF-7 nuclear extracts retained the ability to bind the NF1 mutated probe, although the intensity of the band shift was diminished compared with the non-mutated probe. Mimosine exposure eliminated the binding activity of nuclear extracts for all probes. Collectively, these data demonstrate that factors present in MCF-7 nuclear extracts bind to the MRE consensus sequence located within the mimosine-responsive promoter fragment Ϫ50 to Ϫ1 (Fig.  2) , but this activity is lost in MCF-7 cells that were exposed to mimosine.
Previously, we described the isolation of the mimosine-resistant MCF-7/2a cell line, which does not exhibit mimosine- induced inhibition of cell cycle or SHMT1 transcription (2). Nuclear extracts isolated from mimosine-treated MCF-7/2a cells retained the ability to bind the probe containing the NF1/MRE consensus sequence (Ϫ50 to Ϫ31) (Fig. 6) . To determine whether the binding activity of another zincrequiring transcription factor was impaired by mimosine, the effect of mimosine on Sp1 binding activity in nuclear extracts was determined. The SHMT1 promoter contains an Sp1 site Ϫ173 to Ϫ165, and this sequence was used to generate a probe for gel mobility shift assay analyses (Fig. 6B) . Nuclear extracts isolated from MCF-7 cells bound the Sp1 probe, whereas nuclear extracts from mimosine-treated cells did not bind the Sp1 probe. However, mimosine treatment did not impair Sp1 binding activity in nuclear extracts from mimosine-resistant MCF-7/2a cells. These data provide strong evidence that mimosine impairs SHMT1 transcription by chelating zinc and thereby inhibits the activity of zinc-dependent transcription factors.
Expression of the SHMT1 Gene Is Zinc-dependent-The effect of zinc availability on CSHMT protein levels was determined in MCF-7 cells by Western blot analyses (Fig. 7) . MCF-7 cells passaged in zinc depleted culture medium (18) displayed a 50% decrease in CSHMT protein levels after 8 days of culture and greater than a 95% decrease from day 16 through day 40. MCF-7 cells passaged in zinc deficient medium that was supplemented with 4 M zinc exhibited similar CSHMT protein levels as those passaged in ␣MEM. Similar effects on CSHMT The binding activity of nuclear extracts isolated from MCF-7 cells and mimosinetreated MCF-7 cells was determined using a probe that represents nucleotide sequence Ϫ50 to Ϫ31 of the SHMT1 promoter, which contains an overlapping NF1/MRE element. The mutated MRE probe contained the nucleotide sequence Ϫ50 to Ϫ31 of the SHMT1 promoter, except the MRE element was changed from 5Ј-TGCGCTC-3Ј to 5Ј-TACAATC-3Ј. The mutated NF1 probe contained the nucleotide sequence Ϫ50 to Ϫ31 of the SHMT1 promoter, except the NF1 element was changed from 5Ј-TTGGCT-3Ј to 5Ј-GAGACT-3Ј. In all cases, the addition of unlabeled probe refers to the nonmutated probe that represents nucleotide sequence Ϫ50 to Ϫ31 of the SHMT1 promoter. The arrow designates the mimosine sensitive band shift.
protein levels were observed for the mimosine-resistant MCF-7/2a cell line (Fig. 7) . DISCUSSION The results of this study establish cis elements that bind zinc finger transcription factors, including MREs and Sp1, as mimosine-responsive transcriptional elements and thereby provide a definitive mechanism for mimosine-induced repression of SHMT1 gene transcription. Iron chelators, including deferiprone and deferoxamine, exhibit appreciable affinity for zinc and can deplete the labile intracellular zinc pool in cultured murine thymocytes (7, 8) . In patients with iron overload, chronic deferiprone treatment is associated with zinc deficiency (7, 24) , and this effect has been proposed to be responsible for triggering thymocyte apoptosis during therapy (7) .
Mimosine impairs the binding activity of the zinc finger proteins MTF-1 and Sp1, an observation that suggests a general mechanism for the effect of mimosine on nuclear processes including replication and transcription. Biological responses elicited by mimosine may result from inhibition of zinc-dependent DNA binding metalloproteins including those involved in DNA replication initiation (25, 26) and translation (27) . Whereas the in vivo zinc chelating activity of mimosine and other iron chelators would be expected to be invariant among cell types, mimosine is a cell-specific inhibitor of both cell cycle and SHMT1 transcription. Previously, we reported the generation of the mimosine-resistant MCF-7/2a cell line, which displayed normal to elevated SHMT1 transcriptional activity in the presence of either mimosine or deferoxamine (2), indicating that the inhibitory effect of mimosine on cell cycle progression and SHMT1 transcription results from a common mechanism (2) . In support of this suggestion, both MFT-1 and Sp1 binding activity is unaffected by mimosine in MCF-7/2a cells, indicating that mimosine cannot effectively prevent the incorporation of zinc into zinc finger DNA binding proteins in this resistant cell line, although SHMT1 expression remains sensitive to zinc depletion of the culture medium (Fig. 7) . Therefore, cellular mimosine resistance is most likely conferred by limiting the cellular accumulation of metal chelators, either by enhancing their metabolism or efflux or by preventing their import, which thereby prevents the sequestration of intracellular zinc.
The regulation of SHMT1 transcription by MTF-1 indicates that zinc status may regulate folate-mediated one-carbon metabolism. The CSHMT enzyme plays a key role in the regulation of folate-mediated one-carbon metabolism; it serves as a metabolic switch that preferentially directs folate-activated one-carbon units into the thymidylate synthesis pathway and impairs the homocysteine remethylation pathway by sequestering 5-methyltetrahydrofolate rendering it unavailable for the remethylation of homocysteine to methionine (13) . Zinc status is known to affect folate-mediated one-carbon metabolism, but the underlying molecular mechanisms have not been established. Zinc deficiency in rats lowers plasma homocysteine concentrations by 65% and reduces hepatic 5-methyltetrahydrofolate concentrations (28) . Although the effects of zinc deficiency on lowering plasma homocysteine and hepatic 5-methyltetrahydrofolate concentrations have been attributed to very modest increases in hepatic methionine synthase activity (28), they are also consistent with an attenuation of SHMT1 expression and subsequent derepression of the homocysteine remethylation cycle. Because human zinc deficiency is common (29) and impairments in folate metabolism are strongly associated with human pathologies including cancers, cardiovascular disease, and developmental anomalies, further investigation into the role of zinc in regulating folate metabolism is clearly warranted.
